EP2542687 - INVOLVEMENT OF ANDROGEN/ANDROGEN RECEPTOR PATHWAY IN FABRY DISEASE [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 07.02.2014 Database last updated on 18.10.2024 | Most recent event Tooltip | 07.02.2014 | Application deemed to be withdrawn | published on 12.03.2014 [2014/11] | Applicant(s) | For all designated states Baylor Research Institute 3310 Live Oak Street, Suite 501 Dallas, TX 75204 / US | [2013/02] | Inventor(s) | 01 /
SHEN, Jinsong 208 Tuscany Court Allen, TX 75013 / US | 02 /
SCHIFFMANN, Raphael 2125 Hillcroft Drive Rockwall, TX 75087 / US | 03 /
MENG, Xingli 208 Tuscany Court Allen, TX 75013 / US | [2013/02] | Representative(s) | SONN Patentanwälte GmbH & Co KG Riemergasse 14 1010 Wien / AT | [N/P] |
Former [2013/02] | Sonn & Partner Patentanwälte Riemergasse 14 1010 Wien / AT | Application number, filing date | 11751240.0 | 01.03.2011 | WO2011US26761 | Priority number, date | US20100310802P | 05.03.2010 Original published format: US 310802 P | [2013/02] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2011109448 | Date: | 09.09.2011 | Language: | EN | [2011/36] | Type: | A1 Application with search report | No.: | EP2542687 | Date: | 09.01.2013 | Language: | EN | The application published by WIPO in one of the EPO official languages on 09.09.2011 takes the place of the publication of the European patent application. | [2013/02] | Search report(s) | International search report - published on: | AU | 09.09.2011 | Classification | IPC: | C12Q1/00, A61P3/00, G01N33/483, A61K38/00, A61P5/26, G01N33/487 | [2013/02] | CPC: |
G01N33/743 (EP,US);
A61P3/00 (EP);
A61P5/26 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2013/02] | Extension states | BA | 05.09.2012 | ME | 05.09.2012 | Title | German: | BETEILIGUNG VON ANDROGEN/ANDROGENREZEPTORPFAD AN MODUS FABRY | [2013/02] | English: | INVOLVEMENT OF ANDROGEN/ANDROGEN RECEPTOR PATHWAY IN FABRY DISEASE | [2013/02] | French: | PARTICIPATION DE VOIE DE SIGNALISATION D'ANDROGÈNES/DU RÉCEPTEUR DES ANDROGÈNES DANS MALADIE DE FABRY | [2013/02] | Entry into regional phase | 05.09.2012 | National basic fee paid | 05.09.2012 | Search fee paid | 05.09.2012 | Designation fee(s) paid | 05.09.2012 | Examination fee paid | Examination procedure | 05.09.2012 | Amendment by applicant (claims and/or description) | 05.09.2012 | Examination requested [2013/02] | 01.10.2013 | Application deemed to be withdrawn, date of legal effect [2014/11] | 29.10.2013 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2014/11] | Fees paid | Penalty fee | Additional fee for renewal fee | 31.03.2013 | 03   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO03086386 (NOVOGEN RES PTY LTD [AU], et al); | [X]WO2008115719 (CURIS INC [US], et al); | [XP]WO2010118330 (BAYLOR RES INST [US], et al); | [A] - HAUSER A.C. ET AL., "Hormonal profile and fertility in patients with Anderson-Fabry disease", INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, (2005), vol. 59, no. 9, pages 1025 - 1028, XP055096265 DOI: http://dx.doi.org/10.1111/j.1742-1241.2005.00620.x |